HIGDON LEO I JR - 03 Aug 2022 Form 4 Insider Report for Enhabit, Inc. (EHAB)

Role: Director
Signature: /s/ Jung H. Lee, as Attorney in Fact
Issuer symbol: EHAB
Transactions as of: 03 Aug 2022
Net transactions value: +$61,065
Form type: 4
Filing time: 05 Aug 2022, 18:06:28 UTC
Previous filing: 06 Jul 2022
Next filing: 08 Aug 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EHAB	Common Stock	Purchase	$61,065	+4,500		$13.57	4,500	03 Aug 2022	By 2016 Exempt Family Trust	F2
holding	EHAB	Common Stock						17,074	03 Aug 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The amount of shares of common stock reported in Column 5 is less than previously reported due to the way Encompass Health Corporation restricted stock units were treated in the separation and distribution from Encompass Health Corporation.
F2	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.45 to $13.71, inclusive. The reporting person undertakes to provide to Enhabit, Inc., any security holder of Enhabit, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Content

The amount of shares of common stock reported in Column 5 is less than previously reported due to the way Encompass Health Corporation restricted stock units were treated in the separation and distribution from Encompass Health Corporation.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.45 to $13.71, inclusive. The reporting person undertakes to provide to Enhabit, Inc., any security holder of Enhabit, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.